Abstract
Pancreatitis complicates 5-15% of ERCPs and results in considerable morbidity. In pancreatitis, hypovolemia and microvascular hypoperfusion are correlated with histologic inflammation and necrosis. Our aim is to assess whether treatment with aggressive intravenous fluids during and after ERCP, which theoretically optimizes perfusion, prevents post ERCP pancreatitis (PEP).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
